» Articles » PMID: 23625813

Glomerular Filtration Rate Equations Overestimate Creatinine Clearance in Older Individuals Enrolled in the Baltimore Longitudinal Study on Aging: Impact on Renal Drug Dosing

Overview
Journal Pharmacotherapy
Specialty Pharmacology
Date 2013 Apr 30
PMID 23625813
Citations 60
Authors
Affiliations
Soon will be listed here.
Abstract

Objectives: To evaluate the performance of kidney function estimation equations and to determine the frequency of drug dose discordance in an older population.

Design: Cross-sectional analysis of data from community-dwelling volunteers randomly selected from the Baltimore Longitudinal Study of Aging from January 1, 2005, to December 31, 2010.

Subjects: A total of 269 men and women with a mean ± SD age of 81 ± 6 years, mean serum creatinine concentration (Scr ) of 1.1 ± 0.4 mg/dl, and mean 24-hour measured creatinine clearance (mClcr ) of 53 ± 13 ml/minute.

Measurements And Main Results: Kidney function was estimated by using the following equations: Cockcroft-Gault (CG), Modification of Diet in Renal Disease (MDRD), and Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI). The performance of each equation was assessed by measuring bias and precision relative to mClcr . Dose calculation errors (discordance) were determined for 10 drugs requiring renal dosage adjustments to avoid toxicity when compared with the dosages approved by the Food and Drug Administration. The CG equation was the least biased estimate of mClcr . The MDRD and CKD-EPI equations were significantly positively biased compared with CG (mean ± SD 34 ± 20% and 22 ± 15%, respectively, p<0.001) and mClcr (29 ± 47% and 18 ± 40%, respectively, p<0.001). Rounding low Scr values (less than 1.0 mg/dl) up to an arbitrary value of 1.0 mg/dl resulted in CG values (44 ± 10 ml/minute) that were significantly lower than mClcr (56 ± 12 ml/minute, p<0.001) and CG (56 ± 15 ml/minute, p<0.001). The MDRD and CKD-EPI equations had median dose discordance rates of 28.6% and 22.9%, respectively.

Conclusion: The MDRD and CKD-EPI equations significantly overestimated creatinine clearance (mClcr and CG) in elderly individuals. This leads to dose calculation errors for many drugs, particularly in individuals with severe renal impairment. Thus equations estimating glomerular filtration rate should not be substituted in place of the CG equation in older adults for the purpose of renal dosage adjustments. In addition, the common practice of rounding or replacing low Scr values with an arbitrary value of 1.0 mg/dl for use in the CG equation should be avoided. Additional studies that evaluate alternative eGFR equations in the older populations that incorporate pharmacokinetic and pharmacodynamic outcomes measures are needed.

Citing Articles

Renal function assessment in older people: comparative analysis of estimation equation with serum creatinine.

Peruzzo S, Ottaviani S, Tagliafico L, Muzyka M, Ponzano M, Marelli C Front Med (Lausanne). 2024; 11:1477500.

PMID: 39697206 PMC: 11652175. DOI: 10.3389/fmed.2024.1477500.


The impact of population ageing on the burden of chronic kidney disease.

Chesnaye N, Ortiz A, Zoccali C, Stel V, Jager K Nat Rev Nephrol. 2024; 20(9):569-585.

PMID: 39025992 DOI: 10.1038/s41581-024-00863-9.


Prevention of Chronic Kidney Disease and Its Complications in Older Adults.

Tungsanga S, Bello A Drugs Aging. 2024; 41(7):565-576.

PMID: 38926293 DOI: 10.1007/s40266-024-01128-7.


The Ultrasound Renal Stress Test for the Assessment of Functional Renal Reserve in Kidney Transplantation: A Pilot Study in Living Donors.

Nalesso F, Martino F, Bogo M, Bettin E, Alessi M, Stefanelli L J Clin Med. 2024; 13(2).

PMID: 38256658 PMC: 10816091. DOI: 10.3390/jcm13020525.


Albumin-bound kynurenic acid is an appropriate endogenous biomarker for assessment of the renal tubular OATs-MRP4 channel.

Ma Y, Ran F, Xin M, Gou X, Wang X, Wu X J Pharm Anal. 2023; 13(10):1205-1220.

PMID: 38024860 PMC: 10657973. DOI: 10.1016/j.jpha.2023.05.007.


References
1.
Nutescu E, Spinler S, Wittkowsky A, Dager W . Low-molecular-weight heparins in renal impairment and obesity: available evidence and clinical practice recommendations across medical and surgical settings. Ann Pharmacother. 2009; 43(6):1064-83. DOI: 10.1345/aph.1L194. View

2.
Legrand M, Mateo J, Aribaud A, Ginisty S, Eftekhari P, Tran Ba Huy P . The use of dabigatran in elderly patients. Arch Intern Med. 2011; 171(14):1285-6. DOI: 10.1001/archinternmed.2011.314. View

3.
Breton G, Froissart M, Janus N, Launay-Vacher V, Berr C, Tzourio C . Inappropriate drug use and mortality in community-dwelling elderly with impaired kidney function--the Three-City population-based study. Nephrol Dial Transplant. 2011; 26(9):2852-9. PMC: 3907357. DOI: 10.1093/ndt/gfq827. View

4.
Shaffer D, Butterfield M, Pamer C, Mackey A . Tardive dyskinesia risks and metoclopramide use before and after U.S. market withdrawal of cisapride. J Am Pharm Assoc (2003). 2005; 44(6):661-5. DOI: 10.1331/1544345042467191. View

5.
Stangier J, Rathgen K, Stahle H, Mazur D . Influence of renal impairment on the pharmacokinetics and pharmacodynamics of oral dabigatran etexilate: an open-label, parallel-group, single-centre study. Clin Pharmacokinet. 2010; 49(4):259-68. DOI: 10.2165/11318170-000000000-00000. View